Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 31:10:67.
doi: 10.12703/r/10-67. eCollection 2021.

Recent advances in testicular germ cell tumours

Teresa Mele  1   2 , Alison Reid  1 , Robert Huddart  1   2
Affiliations
Review

Recent advances in testicular germ cell tumours

Teresa Mele et al. Fac Rev. .

Abstract

Testicular germ cell tumours (TGCTs) are the most common solid tumours in young men and have an excellent overall cure rate and prognosis. In most patients, localised disease is cured by surgery alone, and a minority of patients receive short-course adjuvant chemotherapy to reduce the risk of further relapse. Also, in about 80% of patients, metastatic disease can be cured by systemic cisplatin-based chemotherapy. Unfortunately, for a proportion of patients, the disease exhibits platinum resistance and relapse occurs. Despite further lines of systemic treatment, cure can be difficult to achieve in these patients and ultimately about 20% of them will die from disease progression. Addressing the mechanisms underpinning platinum resistance is critical to improving the survival and chances of cure for these patients. This review describes the latest advances in TGCT research, focusing on the identification of novel biomarkers, genetic characteristics and exploring novel treatments.

Keywords: biomarkers; genetic hallmarks; germ cell cancer; novel treatments; testicular germ cell tumours.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.No competing interests were disclosed.No competing interests were disclosed.

References

    1. Bosl GJ, Motzer RJ: Testicular germ-cell cancer. N Engl J Med. 1997; 337(4): 242–53. 10.1056/NEJM199707243370406 - DOI - PubMed
    1. Horwich A, Shipley J, Huddart R: Testicular germ-cell cancer. Lancet. 2006; 367(9512): 754–65. 10.1016/S0140-6736(06)68305-0 - DOI - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, et al. : Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424. 10.3322/caac.21492 - DOI - PubMed

    2. Faculty Opinions Recommendation

    1. Gurney JK, Florio AA, Znaor A, et al. : International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries. Eur Urol. 2019; 76(5): 615–23. 10.1016/j.eururo.2019.07.002 - DOI - PMC - PubMed

    2. Faculty Opinions Recommendation

    1. Moch H, Cubilla AL, Humphrey PA, et al. : The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016; 70(1): 93–105. 10.1016/j.eururo.2016.02.029 - DOI - PubMed

LinkOut - more resources